GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vireo Growth Inc (FRA:0ZF) » Definitions » Cyclically Adjusted PS Ratio

Vireo Growth (FRA:0ZF) Cyclically Adjusted PS Ratio : 0.54 (As of Jun. 01, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Vireo Growth Cyclically Adjusted PS Ratio?

As of today (2025-06-01), Vireo Growth's current share price is €0.29. Vireo Growth's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was €0.54. Vireo Growth's Cyclically Adjusted PS Ratio for today is 0.54.

The historical rank and industry rank for Vireo Growth's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:0ZF' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.17   Med: 0.94   Max: 12.29
Current: 0.55

During the past years, Vireo Growth's highest Cyclically Adjusted PS Ratio was 12.29. The lowest was 0.17. And the median was 0.94.

FRA:0ZF's Cyclically Adjusted PS Ratio is ranked better than
84.55% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.12 vs FRA:0ZF: 0.55

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Vireo Growth's adjusted revenue per share data for the three months ended in Mar. 2025 was €0.062. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €0.54 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Vireo Growth Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Vireo Growth's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vireo Growth Cyclically Adjusted PS Ratio Chart

Vireo Growth Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.13 2.66 0.26 0.36 0.92

Vireo Growth Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.70 0.73 0.92 0.72

Competitive Comparison of Vireo Growth's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Vireo Growth's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vireo Growth's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vireo Growth's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Vireo Growth's Cyclically Adjusted PS Ratio falls into.


;
;

Vireo Growth Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Vireo Growth's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.29/0.54
=0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vireo Growth's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Vireo Growth's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.062/134.9266*134.9266
=0.062

Current CPI (Mar. 2025) = 134.9266.

Vireo Growth Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.000 100.684 0.000
201509 0.000 100.392 0.000
201512 0.000 99.792 0.000
201603 0.000 100.470 0.000
201606 0.000 101.688 0.000
201609 0.000 101.861 0.000
201612 0.000 101.863 0.000
201703 0.000 102.862 0.000
201706 0.000 103.349 0.000
201709 0.000 104.136 0.000
201712 0.000 104.011 0.000
201803 0.000 105.290 0.000
201806 0.000 106.317 0.000
201809 0.000 106.507 0.000
201812 0.000 105.998 0.000
201903 0.086 107.251 0.108
201906 0.257 108.070 0.321
201909 0.267 108.329 0.333
201912 0.115 108.420 0.143
202003 0.124 108.902 0.154
202006 0.110 108.767 0.136
202009 0.094 109.815 0.115
202012 0.098 109.897 0.120
202103 0.095 111.754 0.115
202106 0.094 114.631 0.111
202109 0.090 115.734 0.105
202112 0.095 117.630 0.109
202203 0.111 121.301 0.123
202206 0.156 125.017 0.168
202209 0.149 125.227 0.161
202212 0.140 125.222 0.151
202303 0.139 127.348 0.147
202306 0.145 128.729 0.152
202309 0.164 129.860 0.170
202312 0.155 129.419 0.162
202403 0.155 131.776 0.159
202406 0.162 132.554 0.165
202409 0.113 133.029 0.115
202412 0.103 133.157 0.104
202503 0.062 134.927 0.062

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Vireo Growth  (FRA:0ZF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Vireo Growth Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Vireo Growth's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Vireo Growth Business Description

Traded in Other Exchanges
Address
207 South 9th Street, Minneapolis, Minneapolis, MN, USA, 55402
Vireo Growth Inc is a cannabis company whose mission is to provide safe access, quality products, and value to its customers while supporting its local communities through active participation and restorative justice programs. The company's operating results in one business segment: the cultivation, production, and sale of cannabis.

Vireo Growth Headlines

No Headlines